NEW YORK (AP) -- Shares of Thoratec Corp. gained ground in aftermarket trading Wednesday after the heart device maker's second-quarter net income and revenue beat Wall Street forecasts on better sales ...

Don't just count the cash, time it. It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" When ...

Thoratec Corp THOR recently announced that the HeartMate III CE mark trial has successfully met its primary endpoint. HeartMate III is a next-generation continuous-flow left ventricular assist device ...

Thoratec Corp. on Wednesday won U.S. approval to sell an implantable heart device as a permanent treatment for patients too sick for transplants, opening a new market for the product. Thoratec already ...

One stock that might be an intriguing choice for investors right now is Thoratec Corp. (THOR). This is because this security in the Medical Instruments space is seeing solid earnings estimate revision ...

Thoratec (Nasdaq: THOR) reported earnings on July 31. Here are the numbers you need to know. The 10-second takeaway For the quarter ended June 29 (Q2), Thoratec beat expectations on revenues and ...

Heart assist device manufacturer Thoratec Corp. has finally found a leader. Nearly six months after Keith Grossman announced he’d be leaving the Pleasanton-based company as its chief executive, ...

We recently downgraded our rating for Thoratec (THOR) to Neutral. Its fourth quarter earnings beat the Zacks Consensus Estimate while profit increased year over year, helped by higher revenues.

Thoratec (NAS: THOR) reported earnings on Feb. 5. Here are the numbers you need to know. The 10-second takeaway For the quarter ended Dec. 29 (Q4), Thoratec beat expectations on revenues and met ...

Forbes contributors publish independent expert analyses and insights. We write about stock options with a focus on yield. Selling a put does not give an investor access to THOR's upside potential the ...

Thoratec Corp. of Pleasanton warned consumers late Tuesday that four patients, including two who improperly used the company's popular heart pump device, had died. The users had experienced problems ...